Patient-reported outcomes and disease activity in giant cell arteritis: a longitudinal registry-based study

OBJECTIVES: The objective of this registry-based cohort study was to evaluate longitudinal associations between disease activity measures and patient-reported outcomes (PROs) in GCA, and to assess whether specific PRO domains reflect clinically active disease. METHODS: Among all GCA patients registered in NorVas up to 12 December 2024, we selected patients who: 1) fulfilled the ACR 1990 classification criteria for GCA, 2) had two PROs recorded at least once, and 3) were included in NorVas at the time of diagnosis. HRQoL was assessed by RAND-12, using the physical (PCS) and mental composite scores (MCS) as outcomes. Visual analogue scales were used to assess pain, fatigue, and global disease assessment. The association between the PROs and disease activity were evaluated using linear mixed effects models. We assessed the PROs over time and the difference in PROs between active and inactive disease. RESULTS: We included 256 patients in the study with a median of 3 observations each, and a total of 1003 observations. All examined PROs showed a significant difference between active and inactive disease at baseline. Statistically and clinically significant differences were retained during follow-up for RAND-12-PCS (11.19 [5.67, 16.71]), pain (-12.64 [-18.58, -6.70]) and global assessment (-9.92 [-15.48, -4.35]). CONCLUSIONS: Our study demonstrates a consistent association between PROs and disease activity in GCA, most pronounced for the physical component of HRQoL, pain and global assessment. Patients with active disease showed statistically and clinically significant differences in PRO scores compared with those in remission, both at baseline and throughout follow‑up. While no single PRO domain can replace formal disease activity assessment, patterns across pain, fatigue and patient global measures may signal active disease and warrant clinical reassessment. Taken together, these findings indicate that selected combinations of PROs may serve as a useful adjunct in the monitoring of GCA.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2026-05-01
DOI
https://doi.org/10.1093/rheumatology/keag233
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient-reported outcomes and disease activity in giant cell arteritis: a longitudinal registry-based study

Lene Kristin Brekke, Jörg Aßmus, Geirmund Myklebust, Hans Kristian Skaug et al.
Lara D. Veeken
Vasculitis and related conditions
article

Patient-reported outcomes and disease activity in giant cell arteritis: a longitudinal registry-based study

Lene Kristin Brekke, Jörg Aßmus, Geirmund Myklebust, Hans Kristian Skaug, Andreas P Diamantopoulos, Bjørg Tilde Fevang
article en

Abstract

OBJECTIVES: The objective of this registry-based cohort study was to evaluate longitudinal associations between disease activity measures and patient-reported outcomes (PROs) in GCA, and to assess whether specific PRO domains reflect clinically active disease. METHODS: Among all GCA patients registered in NorVas up to 12 December 2024, we selected patients who: 1) fulfilled the ACR 1990 classification criteria for GCA, 2) had two PROs recorded at least once, and 3) were included in NorVas at the time of diagnosis. HRQoL was assessed by RAND-12, using the physical (PCS) and mental composite scores (MCS) as outcomes. Visual analogue scales were used to assess pain, fatigue, and global disease assessment. The association between the PROs and disease activity were evaluated using linear mixed effects models. We assessed the PROs over time and the difference in PROs between active and inactive disease. RESULTS: We included 256 patients in the study with a median of 3 observations each, and a total of 1003 observations. All examined PROs showed a significant difference between active and inactive disease at baseline. Statistically and clinically significant differences were retained during follow-up for RAND-12-PCS (11.19 [5.67, 16.71]), pain (-12.64 [-18.58, -6.70]) and global assessment (-9.92 [-15.48, -4.35]). CONCLUSIONS: Our study demonstrates a consistent association between PROs and disease activity in GCA, most pronounced for the physical component of HRQoL, pain and global assessment. Patients with active disease showed statistically and clinically significant differences in PRO scores compared with those in remission, both at baseline and throughout follow‑up. While no single PRO domain can replace formal disease activity assessment, patterns across pain, fatigue and patient global measures may signal active disease and warrant clinical reassessment. Taken together, these findings indicate that selected combinations of PROs may serve as a useful adjunct in the monitoring of GCA.

Lara D. Veeken
Akershus University Hospital (NO), Haukeland University Hospital (NO), Hospital of Southern Norway (NO), Institute for Rheumatic Diseases (Japan) (JP), University of Bergen (NO)
Good health and well-being
Openalex Percentile: Top 7%
Vasculitis and related conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.